With a host of possible symptoms that are often confused with other disorders, lupus is often referred to as "the great imposter." The symptoms of lupus vary, and most people who have lupus may only experience ...

Abstract BACKGROUND: Lupus nephritis is the renal manifestation of systemic lupus erythematosus - a disease mainly affecting young women with substantial morbidity and mortality.

NEW YORK -- Drugs used to treat malaria appear to reduce the risk of malignancy in patients with systemic lupus erythematosus...

Main Category: Dermatology News Article Date: 17 Jul 2007 - 1:00 PDT newsletters Relieva - a clinically proven, steroid-free treatment for mild-to-moderate-plaque psoriasis - has been launched by Apollo ...

Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug 19 July 2007 Mumbai: Lupin Ltd has received approval from the Drugs Controller General of India to conduct a combined phase-IIb ...

"We are excited that BCX-4208 is advancing into Phase II testing"

BioCryst Pharmaceuticals, Inc. and Roche initiated the first Phase II study to evaluate BCX-4208/R3421 in patients with moderate to severe plaque psoriasis.

"This multi-dose study marks an important milestone in MedImmune's efforts to develop innovative treatments for inflammatory diseases such as lupus"

Patients With Lupu A study to evaluate the safety and tolerability of multiple doses of the MAb in patients with systemic lupus erythematosus .

MedImmune, Inc. announced that it has begun dosing patients in a multi-dose, Phase 1b clinical trial with its monoclonal antibody targeting interferon-alpha, known as MEDI-545. &